I'm LongbridgeAI, I can summarize articles.Zimmer Biomet Holdings Inc. (ZBH) stock rose 1.27% to $97.78, outperforming the broader market and snapping a two-day losing streak despite a generally dismal trading session. The S&P 500 and Dow Jones fell slightly. ZBH closed 9.71% below its 52-week high. Trading volume of 3.3 million shares exceeded the 50-day average. Competitors Johnson & Johnson, Medtronic, and Stryker also saw gains.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Zimmer Biomet Holdings Inc. (ZBH) advanced 1.27% to $97.78 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.06% to 7,753.11 and Dow Jones Industrial Average falling 0.11% to 53,975.98.
The stock's rise snapped a two-day losing streak.
Zimmer Biomet Holdings Inc. closed 9.71% below its 52-week high of $108.29, which the company achieved on August 26th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) rose 0.99% to $261.81, Medtronic PLC (MDT) rose 2.58% to $89.41, and Stryker Corp. (SYK) rose 2.00% to $345.81.
Trading volume (3.3 M) eclipsed its 50-day average volume of 2.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 10, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-10-26 1710ET